2017
Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice
Donroe JH, Holt SR, O’Connor P, Sukumar N, Tetrault JM. Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice. Drug And Alcohol Dependence 2017, 180: 46-51. PMID: 28866369, DOI: 10.1016/j.drugalcdep.2017.07.040.Peer-Reviewed Original ResearchConceptsOpioid use disorderUrine buprenorphineNorbuprenorphine levelsUrine adulterationAddiction treatment clinicsTreatment clinicsBuprenorphine medicationSublingual buprenorphineBuprenorphine treatmentTreatment cohortsRetrospective studyUrine specimenBuprenorphineUse disordersPatientsClinical practiceUrine samplesUrineClinicTreatmentMedicationsLevelsNorBUPCohortSuspicion
2013
Instruments to assess patient‐reported safety, efficacy, or misuse of current opioid therapy for chronic pain: A systematic review
Becker WC, Fraenkel L, Edelman J, Holt SR, Glover J, Kerns RD, Fiellin DA. Instruments to assess patient‐reported safety, efficacy, or misuse of current opioid therapy for chronic pain: A systematic review. Pain 2013, 154: 905-916. PMID: 23601625, PMCID: PMC3683236, DOI: 10.1016/j.pain.2013.02.031.Peer-Reviewed Original ResearchConceptsPatient-reported safetyOpioid therapyChronic painInclusion criteriaSystematic reviewOngoing opioid therapyPsychometric testsLack of testingEligible studiesClinical practiceInitial searchStatistical significanceDiagnostic accuracy testingPainEfficacyTherapyEfficacy itemsContent expertsSafetyLimited assessmentReviewLiterature reviewGeneralizability limitationsFurther researchIndividual items